Breaking News

Sai Life Sciences Expands DMPK Services

Adds 25,000 sq. ft. of labs and new global talent.

Author Image

By: Charlie Sternberg

Associate Editor

To offer global big pharma clients cutting-edge, end-to-end drug metabolism and pharmacokinetics (DMPK) services, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), has expanded its DMPK capabilities with the addition of 25,000 sq. ft. of labs equipped with cutting-edge instrumentation enabling high-end automation.   Complementing the expansion has been the hiring of talent globally resulting in nearly 3x growth of the team size.   Krishna...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters